Eris Lifesciences informs about company updates

17 Jun 2019 Evaluate

As per the requirements of Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Eris Lifesciences has informed that it has enclosed the details of the related party transactions on a consolidated basis for the year ended 31st March, 2019 in accordance with the format prescribed in the relevant accounting standards.

The above information is a part of company’s filings submitted to BSE.

Eris Lifesciences Share Price

1389.70 -22.85 (-1.62%)
18-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.30
Dr. Reddys Lab 1275.05
Cipla 1472.05
Lupin 2098.70
Zydus Lifesciences 979.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.